Research and Markets: Alopecia Pipeline Review, H2 2015

[Renee1]

[FONT=Verdana, Arial, Tahoma, Calibri, Geneva, sans-serif]Companies Involved in Therapeutics Development[/FONT]

• [FONT=Verdana, Arial, Tahoma, Calibri, Geneva, sans-serif]Allergan Plc[/FONT]
• [FONT=Verdana, Arial, Tahoma, Calibri, Geneva, sans-serif]AndroScience Corporation[/FONT]
• [FONT=Verdana, Arial, Tahoma, Calibri, Geneva, sans-serif]Berg, LLC[/FONT]
• [FONT=Verdana, Arial, Tahoma, Calibri, Geneva, sans-serif]Bristol-Myers Squibb Company[/FONT]
• [FONT=Verdana, Arial, Tahoma, Calibri, Geneva, sans-serif]Dong-A Socio Group[/FONT]
• [FONT=Verdana, Arial, Tahoma, Calibri, Geneva, sans-serif]Follicum AB[/FONT]
• [FONT=Verdana, Arial, Tahoma, Calibri, Geneva, sans-serif]Histogen, Inc.[/FONT]
• [FONT=Verdana, Arial, Tahoma, Calibri, Geneva, sans-serif]Hyundai Pharmaceutical Co., Ltd.[/FONT]
• [FONT=Verdana, Arial, Tahoma, Calibri, Geneva, sans-serif]Kuhnil Pharmaceutical Co., Ltd.[/FONT]
• [FONT=Verdana, Arial, Tahoma, Calibri, Geneva, sans-serif]Kythera Biopharmaceuticals, Inc.[/FONT]
• [FONT=Verdana, Arial, Tahoma, Calibri, Geneva, sans-serif]Lee's Pharmaceutical Holdings Limited[/FONT]
• [FONT=Verdana, Arial, Tahoma, Calibri, Geneva, sans-serif]Panacea Biotec Limited[/FONT]
• [FONT=Verdana, Arial, Tahoma, Calibri, Geneva, sans-serif]Polichem S.A.[/FONT]
• [FONT=Verdana, Arial, Tahoma, Calibri, Geneva, sans-serif]R-Tech Ueno, Ltd.[/FONT]
• [FONT=Verdana, Arial, Tahoma, Calibri, Geneva, sans-serif]RepliCel Life Sciences, Inc.[/FONT]
• [FONT=Verdana, Arial, Tahoma, Calibri, Geneva, sans-serif]RestorGenex Corporation[/FONT]
• [FONT=Verdana, Arial, Tahoma, Calibri, Geneva, sans-serif]RXi Pharmaceuticals Corporation[/FONT]
• [FONT=Verdana, Arial, Tahoma, Calibri, Geneva, sans-serif]SWITCH Biotech LLC[/FONT]
• [FONT=Verdana, Arial, Tahoma, Calibri, Geneva, sans-serif]Taisho Pharmaceutical Co., Ltd.[/FONT]
• [FONT=Verdana, Arial, Tahoma, Calibri, Geneva, sans-serif]Tigo GmbH[/FONT]
• [FONT=Verdana, Arial, Tahoma, Calibri, Geneva, sans-serif]Valeant Pharmaceuticals International, Inc.[/FONT]
• [FONT=Verdana, Arial, Tahoma, Calibri, Geneva, sans-serif]Vida Therapeutics Inc.[/FONT]

[FONT=Verdana, Arial, Tahoma, Calibri, Geneva, sans-serif]For more information visit http://www.researchandmarkets.com/research/ffttdt/alopecia[/FONT]
[FONT=Verdana, Arial, Tahoma, Calibri, Geneva, sans-serif][/FONT]
[FONT=Verdana, Arial, Tahoma, Calibri, Geneva, sans-serif]View source version on businesswire.com: http://www.businesswire.com/news/home/20151106005890/en/[/FONT]

 

[Giiizmo]

Which one of these represents Samumed?

 

[distracted]

Anyone have some insight into which one looks the most promising?

 

[distracted]

Allergan

http://www.wsj.com/articles/allergan-changes-its-2-1-billion-deal-for-kythera-to-all-cash-1438778826

Kythera was the company sponsoring Dr Cotsareli's work. If i were the CEO of Allergan, I would probably pack all the cash into suitcases and deliver them to Kythera HQ in a limousine myself

Are you saying the most promising treatment to come from that entire list is Setipiprant? The current drug people are trialling that has had zero updates, likely due to zero results?

 

[Dench57]

Are you saying the most promising treatment to come from that entire list is Setipiprant? The current drug people are trialling that has had zero updates, likely due to zero results?